Skip to content
  • Sunday, 26 July 2026
  • 2:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients
Neuroscience & Brain Research

University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients

Rifan Muazin Jun 27, 2026 0

A groundbreaking study led by researchers at the University of Florida has uncovered a potential link between the use of…

Read More
Neuroscience & Brain Research

Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease

Rifan Muazin Jun 27, 2026 0

Researchers at the University of California, Riverside (UCR) have unveiled a provocative new theory regarding the molecular origins of Alzheimer’s…

Read More
Neuroscience & Brain Research

Breakthrough Molecule OLE Offers New Hope for Restoring Brain Immune Function in Alzheimer Disease Patients

Rifan Muazin Jun 27, 2026 0

In a significant advancement for neurodegenerative research, a collaborative team of scientists from Spain and Switzerland has identified an experimental…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 26, 2026 0

Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…

Read More
Neuroscience & Brain Research

Monash University Researchers Identify Copper-Based Drug as Potential Breakthrough in Alzheimer’s Treatment by Restoring Brain Waste Removal Systems

Rifan Muazin Jun 25, 2026 0

A team of researchers at Monash University has unveiled a significant discovery that could redefine the therapeutic landscape for Alzheimer’s…

Read More
Neuroscience & Brain Research

Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research

Rifan Muazin Jun 21, 2026 0

Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…

Read More
Neuroscience & Brain Research

Genetic Mutations Shared by Cancer and Blood Cells Identified as Potential Drivers of Alzheimer’s Disease Pathogenesis

Rifan Muazin Jun 20, 2026 0

Recent breakthroughs in genomic sequencing have fundamentally altered our understanding of how the human body ages, revealing that the genetic…

Read More
Neuroscience & Brain Research

Molecular Switch Identified in Alzheimer’s Brain Inflammation Offers New Therapeutic Target

Rifan Muazin Jun 20, 2026 0

The human brain possesses an intricate, internal defense system designed to patrol for pathogens and clear away cellular debris, yet…

Read More
Neuroscience & Brain Research

Scientists May Have Found What Really Triggers Alzheimer’s Disease

Rifan Muazin Jun 19, 2026 0

A groundbreaking study from the University of California, Riverside, suggests that the traditional understanding of Alzheimer’s disease may require a…

Read More
Neuroscience & Brain Research

ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection

Rifan Muazin Jun 18, 2026 0

A multidisciplinary research team at ETH Zurich has announced the discovery of a novel experimental substance, currently designated as Compound…

Read More

Posts pagination

1 2 3 4 … 9
Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic InterruptionRapid Evolution and Explosive Growth of Chronic Myeloid Leukemia Revealed by Genomic MappingChildhood Dietary Habits Found to Cause Lasting Neurological Changes to Appetite Control SystemsLifelong Cognitive Enrichment Linked to Significant Delays in Alzheimer’s Onset and Cognitive Decline
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ